Evaxion A (EVAX) Exchange Rate Effect (2020 - 2022)
Evaxion A (EVAX) reported Exchange Rate Effect of -$590000.0 for Q2 2022, down 734.41% on a YoY basis from $93000.0 in Q2 2021, and down 293.33% quarter-over-quarter from -$150000.0 in Q1 2022.
Evaxion A (EVAX) Exchange Rate Effect (2020 - 2022) Analysis & Trends
Evaxion A has reported Exchange Rate Effect for 3 years, with the latest figure at -$590000.0 in Q2 2022.
- For the quarter ending Q2 2022, Exchange Rate Effect fell 734.41% year-over-year to -$590000.0; the trailing twelve-month figure through Jun 2022 stood at -$718000.0 (down 350.17% YoY), and the FY2025 full-year result was $1.5 million, up 725.68% from the prior year.
- Exchange Rate Effect for Q2 2022 stood at -$590000.0, down from -$150000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $231000.0 in Q1 2021, with the low at -$590000.0 in Q2 2022.
- Historically, Exchange Rate Effect has averaged -$86125.0 across 3 years, with a median of -$65000.0 in 2020.
- Annual changes were most pronounced in 2021 — Exchange Rate Effect soared 257.63% — and 2022, when it sank 734.41%.
- Evaxion A's Exchange Rate Effect stood at $22000.0 in 2020, then sank by 422.73% to -$71000.0 in 2021, then sank by 730.99% to -$590000.0 in 2022.
- The last three Exchange Rate Effect figures came in at -$590000.0 (Q2 2022), -$150000.0 (Q1 2022), and -$71000.0 (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -900,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -590,000.00 |
| Jun 30, 2022 | -590,000.00 |
| Mar 31, 2022 | -150,000.00 |
| Mar 31, 2022 | -150,000.00 |
| Sep 30, 2021 | -71,000.00 |
| Sep 30, 2021 | -71,000.00 |
| Jun 30, 2021 | 93,000.00 |
| Jun 30, 2021 | 93,000.00 |
| Mar 31, 2021 | 231,000.00 |
| Mar 31, 2021 | 231,000.00 |
| Sep 30, 2020 | 22,000.00 |
| Sep 30, 2020 | 22,000.00 |
| Jun 30, 2020 | -59,000.00 |
| Jun 30, 2020 | -59,000.00 |
| Mar 31, 2020 | -165,000.00 |
| Mar 31, 2020 | -165,000.00 |